Clinical Research Directory
Browse clinical research sites, groups, and studies.
RMP-A03 Ocular Suspension in Patients With Pterygium
Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.
Summary
The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.
Official title: A Phase 1/2a Study Evaluating the Safety and Efficacy of RMP-A03 Ocular Suspension in Healthy Volunteers and Patients With Pterygium
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
77
Start Date
2023-06-09
Completion Date
2024-01-12
Last Updated
2026-06-05
Healthy Volunteers
No
Conditions
Interventions
RMP-A03 - Dose 1
Patients will randomized to low dose of RMP-A03
RMP-A03 - Dose 2
Patients will be randomized to high dose of RMP-A03
RMP-A03 Placebo
Patients will be randomized to RMP-A03 Placebo
Locations (6)
Global Research Management
Glendale, California, United States
United Medical Research Institute
Inglewood, California, United States
Eye Research Foundation Inc
Newport Beach, California, United States
Oceane7 Medical & Research Center Inc.
Miami, Florida, United States
Toyos Clinic
Nashville, Tennessee, United States
Keystone Research
Austin, Texas, United States